Literature DB >> 21729414

Beliefs about medications predict adherence to antidepressants in older adults.

Waleed Fawzi1, Mohamed Yousry Abdel Mohsen, Abdel Hamid Hashem, Suaad Moussa, Elizabeth Coker, Kenneth C M Wilson.   

Abstract

BACKGROUND: Adherence to treatment is a complex and poorly understood phenomenon. This study investigates the relationship between older depressed patients' adherence to antidepressants and their beliefs about and knowledge of the medication.
METHODS: Assessment was undertaken of 108 outpatients over the age of 55 years diagnosed with depressive disorder and treated for at least four weeks with antidepressants. Adherence was assessed using two self-report measures: the Medication Adherence Rating Scale (MARS) and a Global Adherence Measure (GAM). Potential predictors of adherence investigated included sociodemographic, medication and illness variables. In addition, 33 carers were interviewed regarding general medication beliefs.
RESULTS: 56% of patients reported 80% or higher adherence on the GAM. Sociodemographic variables were not associated with adherence on the MARS. Specific beliefs about medicines, such as "my health depends on antidepressants" (necessity) and being less worried about becoming dependant on antidepressants (concern) were highly correlated with adherence. General beliefs about medicines causing harm or being overprescribed, experiencing medication side-effects and severity of depression also correlated with poor adherence. Linear regression with the MARS as the dependent variable explained 44.3% of the variance and showed adherence to be higher in subjects with healthy specific beliefs who received more information about antidepressants and worse with depression severity and autonomic side-effects.
CONCLUSIONS: Our findings strongly support a role for specific beliefs about medicines in adherence. Challenging patients' beliefs, providing information about treatment and discussing side-effects could improve adherence. Poor response to treatment and medication side-effects can indicate poor adherence and should be considered before switching medications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21729414     DOI: 10.1017/S1041610211001049

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  14 in total

1.  [Attitudes towards anti-depressive therapy: acceptance vs. stigmatization].

Authors:  Romina Koller; Helmuth Haslacher; Klemens Kienesberger; Michaela Schmöger; Alexandra Schosser
Journal:  Neuropsychiatr       Date:  2015-02-24

Review 2.  What are validated self-report adherence scales really measuring?: a systematic review.

Authors:  Thi-My-Uyen Nguyen; Adam La Caze; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

3.  Risk factors for non-adherence to antidepressant treatment in patients with mood disorders.

Authors:  Carlos De las Cuevas; Wenceslao Peñate; Emilio J Sanz
Journal:  Eur J Clin Pharmacol       Date:  2013-09-08       Impact factor: 2.953

4.  Illness Beliefs, Treatment Beliefs and Information Needs as Starting Points for Patient Information: The Evaluation of an Intervention for Patients with Depression.

Authors:  Manuela Glattacker; Katja Heyduck; Cornelia Meffert; Teresa Jakob
Journal:  J Clin Psychol Med Settings       Date:  2018-09

5.  Knowledge and Preferences Regarding Antidepressant Medication Among Depressed Latino Patients in Primary Care.

Authors:  Bonnie L Green; Maria Rosa Watson; Stacey I Kaltman; Adriana Serrano; Nicholas Talisman; Laura Kirkpatrick; Marcela Campoli
Journal:  J Nerv Ment Dis       Date:  2017-12       Impact factor: 2.254

6.  Older adults with severe, treatment-resistant depression.

Authors:  Jürgen Unützer; Mijung Park
Journal:  JAMA       Date:  2012-09-05       Impact factor: 56.272

7.  Behavioural activation therapy for depression in adults with non-communicable diseases.

Authors:  Eleonora Uphoff; Malini Pires; Corrado Barbui; Deepa Barua; Rachel Churchill; Doriana Cristofalo; David Ekers; Edward Fottrell; Papiya Mazumdar; Marianna Purgato; Rusham Rana; Judy Wright; Najma Siddiqi
Journal:  Cochrane Database Syst Rev       Date:  2020-08-06

8.  BEFRIENding for Depression, Anxiety and Social support in older adults living in Australian residential aged care facilities (BEFRIENDAS): randomised controlled trial protocol.

Authors:  Colleen Doyle; Sunil Bhar; Christina Bryant; Briony Dow; David Dunt; George Mnatzaganian; Daniel O'Connor; Julie Ratcliffe; Emily You; Anne-Marie Bagnall; Georgia Major; Robin Harper; Marcia Fearn
Journal:  BMC Geriatr       Date:  2021-05-12       Impact factor: 3.921

9.  Behavioural activation therapy for depression in adults.

Authors:  Eleonora Uphoff; David Ekers; Lindsay Robertson; Sarah Dawson; Emily Sanger; Emily South; Zainab Samaan; David Richards; Nicholas Meader; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2020-07-06

Review 10.  Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework.

Authors:  Rob Horne; Sarah C E Chapman; Rhian Parham; Nick Freemantle; Alastair Forbes; Vanessa Cooper
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.